Cvi Holdings, LLC Liquidia Corp Transaction History

Cvi Holdings, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$4.34 - $8.28 $1.15 Million - $2.2 Million	-265,773 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$4.86 - $11.44 $1.29 Million - $3.04 Million	265,773 New	265,773 $2.24 Million
Q2 2019 Aug 14, 2019	SELL	$7.92 - $11.39 $229,577 - $330,161	-28,987 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$10.82 - $21.79 $313,639 - $631,626	28,987 New	28,987 $330,000

162

36M

1.79M

380K

Ticker LQDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,362,300
Market Cap $709M
Description
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...

Get notified when there are updates to the investment portfolio of Cvi Holdings, LLC, based on Form 13F filings with the SEC.

Stay updated on Cvi Holdings, LLC with notifications on news.